Picture of virus

Open Access research that helps to deliver "better medicines"...

Strathprints makes available scholarly Open Access content by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), a major research centre in Scotland and amongst the UK's top schools of pharmacy.

Research at SIPBS includes the "New medicines", "Better medicines" and "Better use of medicines" research groups. Together their research explores multidisciplinary approaches to improve understanding of fundamental bioscience and identify novel therapeutic targets with the aim of developing therapeutic interventions, investigation of the development and manufacture of drug substances and products, and harnessing Scotland's rich health informatics datasets to inform stratified medicine approaches and investigate the impact of public health interventions.

Explore Open Access research by SIPBS. Or explore all of Strathclyde's Open Access research...

Strathprints

Modelling the spread of hepatitis c virus infection among injecting drug users in Glasgow: implications for prevention

Hutchinson, S. and Bird, S.M. and Taylor, A. and Goldberg, D.J. (2006) Modelling the spread of hepatitis c virus infection among injecting drug users in Glasgow: implications for prevention. International Journal of Drug Policy, 17 (3). pp. 211-221. ISSN 0955-3959

Full text not available in this repository. Request a copy from the Strathclyde author

Abstract

Stochastic simulation was used to model quantitatively the transmission of HCV through the sharing of used needles/syringes among IDUs in Glasgow. This combined information on (a) the incidence and cessation of injecting drug use, (b) the frequencies with which IDUs injected and shared needles/syringes, and (c) the susceptibility, transmissibility and carriage of HCV infection. The model that considered higher infectivity following infection produced seroprevalences (median: 62–72%) and incidences (18–30 per 100 susceptible injector-years) consistent with observed data during the 1990s. The annual number of new HCV infections among Glasgow IDUs was estimated to be low during 1960–1976 (median: 10–60), rise steeply during the early 1980s to peak in 1985 (1120), stabilise during 1991–1997 (510–610) and rise again during 1998–2000 (710–780). Scenario analyses indicated that 4500 HCV infections (10th–90th percentiles: 2400–7700) had potentially been prevented in Glasgow during 1988–2000 as a result of harm-reduction measures. Also, HCV incidence can be successfully reduced if IDUs who, unavoidably, share needles/syringes confine their borrowing to one person; with this strategy alone, an estimated 5300 HCV infections (10th–90th percentiles: 4100–6700) could have been averted in Glasgow during 1988–2000. Such insights will inform those responsible for developing new ways to prevent HCV transmission among IDU populations.

Item type: Article
ID code: 10955
Keywords: hepatitis c virus, harm reduction, prevention, Modelling, Injecting drug use, Probabilities. Mathematical statistics, Health Policy, Medicine (miscellaneous)
Subjects: Science > Mathematics > Probabilities. Mathematical statistics
Department: Faculty of Science > Mathematics and Statistics
Faculty of Science > Mathematics and Statistics > Statistics and Modelling Science
Depositing user: Strathprints Administrator
Date deposited: 11 Oct 2011 09:49
Last modified: 28 Mar 2018 08:07
URI: https://strathprints.strath.ac.uk/id/eprint/10955
Export data:
CORE (COnnecting REpositories)